• Lung cancer drug 'could prevent metastases spreading'
    Zoledronic acid may have duel purpose

News & Views

Lung cancer drug 'could prevent metastases spreading'

Feb 25 2011

Scientists have discovered a lung cancer drug could have a duel purpose in tackling the condition.

Dr Michela Quirino and colleagues from the Catholic University of the Sacred Heart in Rome announced the laboratory news after investigating how zoledronic acid may be able to prevent the cancer from spreading.

Currently, the drug is used to help treat bone metastases but the study suggests it may also be useful in the initial stages of the disease.

Dr Quirino said: "If further studies should confirm a possible anti-metastatic effect of this drug ... it could be introduced in the early management of the disease, even as an adjuvant therapy."

The expert conducted a trial on 41 patients with advanced lung cancer and concluded that the evidence implies zoledronic acid may prevent the metastases from recruiting the blood vessels they need to survive.

Zoledronic acid is also used to treat high levels of calcium in the blood.
 

Digital Edition

LMUK 49.7 Nov 2024

November 2024

News - Research & Events News   - News & Views Articles - They’re burning the labs... Spotlight Features - Incubators, Freezers & Cooling Equipment - Pumps, Valves & Liquid Hand...

View all digital editions

Events

MEDICA 2024

Nov 11 2024 Dusseldorf, Germany

FILTECH

Nov 12 2024 Cologne, Germany

Intech

Nov 12 2024 Tel Aviv, Israel

analytica China

Nov 18 2024 Shanghai, China

Pharma Asia

Nov 20 2024 Karachi, Pakistan

View all events